Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open and closed-loop control systems01:17

Open and closed-loop control systems

Control systems are foundational elements in automation and engineering. They are broadly categorized into open-loop and closed-loop systems. These classifications hinge on the presence or absence of feedback mechanisms, significantly influencing the system's performance, complexity, and application.
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal and...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study.

BMJ open·2026
Same author

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Diabetes & metabolism·2025
Same author

Adipose tissue insulin resistance in children and adolescents: linking glucose and free fatty acid metabolism to hepatic injury markers.

American journal of physiology. Endocrinology and metabolism·2024
Same author

Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report.

American journal of medical genetics. Part A·2024
Same author

High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes.

Diabetes research and clinical practice·2023
Same author

Temporal optimization of exercise to lower fasting glucose levels.

The Journal of physiology·2023
Same journal

SleepConFormer: A Single-Channel EEG Framework for Sleep Staging and Consciousness Assessment in Patients with Disorders of Consciousness.

IEEE transactions on bio-medical engineering·2026
Same journal

Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework.

IEEE transactions on bio-medical engineering·2026
Same journal

A Low-Cost Wearable TI-TACS Stimulator With Bipolar Quadratic-Boost Converter for Current Stimulation Validation in the Rat Brain.

IEEE transactions on bio-medical engineering·2026
Same journal

EMG-Based Gait Estimation Using Koopman-Inspired Method.

IEEE transactions on bio-medical engineering·2026
Same journal

Soft Everting Robots for Medical Applications: A Review.

IEEE transactions on bio-medical engineering·2026
Same journal

Arterial spin labeling cerebral blood flow quantification from quantitative transport mapping based on multiscale fluid mechanics simulation and deep learning.

IEEE transactions on bio-medical engineering·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Modular closed-loop control of diabetes.

S D Patek1, L Magni, E Dassau

  • 1Center for Diabetes Technology and Department of Systems and Information Engineering, University of Virginia, Charlottesville, VA 22904-4747, USA. patek@virginia.edu

IEEE Transactions on Bio-Medical Engineering
|April 7, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces a modular artificial pancreas architecture for diabetes control. The system effectively reduces hypoglycemia and glycemic variability, enhancing patient safety and real-time glucose management.

More Related Videos

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level
11:49

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level

Published on: November 17, 2013

Related Experiment Videos

Last Updated: May 23, 2026

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level
11:49

Quantitative and Temporal Control of Oxygen Microenvironment at the Single Islet Level

Published on: November 17, 2013

Area of Science:

  • Biomedical Engineering
  • Control Systems Engineering
  • Endocrinology

Background:

  • Modularity is crucial in engineering for flexible and adaptable systems.
  • In diabetes management, modularity enables phased introduction and regulatory approval of artificial pancreas components.
  • Current artificial pancreas systems can benefit from enhanced modular architectures for improved safety and efficacy.

Purpose of the Study:

  • To introduce a novel three-layer modular architecture for artificial pancreas systems.
  • To separate critical functions of insulin recommendation and safety monitoring.
  • To evaluate the performance of this modular architecture in silico.

Main Methods:

  • Development of a three-layer modular architecture: Interface Module (IM), Continuous Safety Module (CSM), and Real-Time Control Module (RTCM).
  • Implementation of specific modules: APS© (IM), Safety Supervision Module (SSM) (CSM), and Range Correction Module (RCM) (RTCM).
  • In silico preclinical trials to assess the integrated system's performance.

Main Results:

  • The Safety Supervision Module (SSM) demonstrated a reduction in hypoglycemia incidence under non-ideal conditions.
  • The Range Correction Module (RCM) effectively reduced glycemic variability.
  • The modular architecture facilitated the separation of safety and control functions.

Conclusions:

  • The proposed three-layer modular architecture provides a robust framework for artificial pancreas development.
  • This modular approach enhances patient safety by preventing hypoglycemia and improves glycemic control.
  • The system's modularity supports phased implementation and regulatory approval of advanced diabetes management technologies.